Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 301–400 of 1,000
Wen, J.-Y., Wei, C., Shah, K., Wong, J., Wang, C., & Chen, H.-S. V. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0363 · Cited by 63
Modeling Timothy Syndrome with iPS Cells
Yazawa, M., & Dolmetsch, R. E. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9444-x · Cited by 61
The Role of Tissue Engineering and Biomaterials in Cardiac Regenerative Medicine
Zhao, Y., Feric, N. T., Thavandiran, N., Nunes, S. S., & Radisic, M. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.027 · Cited by 63
Human induced pluripotent stem cells—from mechanisms to clinical applications
Drews, K., Józefczuk, J., Prigione, A., & Adjaye, J. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0913-0 · Cited by 69
Uosaki, H., Magadum, A., Seo, K., Fukushima, H., Takeuchi, A., Nakagawa, Y., Moyes, K. W., Narazaki, G., Kuwahara, K., Laflamme, M. A., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000330 · Cited by 63
Engineered Biomaterials to Enhance Stem Cell‐Based Cardiac Tissue Engineering and Therapy
Hasan, A., Waters, R., Roula, B., Rahbani, D., Yara, S., Alexandre, T., & Paul, A. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201500396 · Cited by 60
Maizels, L., Huber, I., Arbel, G., Tijsen, A. J., Gepstein, A., Khoury, A., & Gepstein, L. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004725 · Cited by 61
Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling
Iglesias‐García, O., Pelacho, B., & Prósper, F. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.04.022 · Cited by 62
Human ether-à-go-go-related potassium channel: exploring SAR to improve drug design
Cavalluzzi, M. M., Imbrici, P., Gualdani, R., Stefanachi, A., Mangiatordi, G. F., Lentini, G., & Nicolotti, O. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.005 · Cited by 62
Cardiac Stem Cell Biology: Glimpse of the Past, Present, and Future
Matsa, E., Sallam, K., & Wu, J. C. (2014) · Circulation Research · doi:10.1161/circresaha.113.302895 · Cited by 60
Generation of Healthy Mice from Gene-Corrected Disease-Specific Induced Pluripotent Stem Cells
Wu, G., Liu, N., Rittelmeyer, I., Sharma, A. D., Sgodda, M., Zaehres, H., Bleidißel, M., Greber, B., Gentile, L., Han, D., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001099 · Cited by 60
Electrospun piezoelectric scaffolds for cardiac tissue engineering
Gomes, M. R., Ferreira, F. C., & Sanjuan‐Alberte, P. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212808 · Cited by 61
Merits and challenges of iPSC-derived organoids for clinical applications
Xu, Z., Yang, J., Xin, X., Liu, C., Li, L., Mei, X., & Li, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1188905 · Cited by 63
Sheng, X., Reppel, M., Nguemo, F., Mohammad, F. I., Kuzmenkin, A., Hescheler, J., & Pfannkuche, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045963 · Cited by 56
Genomic Editing Tools to Model Human Diseases with Isogenic Pluripotent Stem Cells
Kim, H. S., Bernitz, J. M., Lee, D., & Lemischka, I. R. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0167 · Cited by 61
Mahida, S., Hogarth, A. J., Cowan, C., Tayebjee, M. H., Graham, L., & Pepper, C. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9779-5 · Cited by 60
Dai, Y., Amenov, A., Ignatyeva, N., Koschinski, A., Xu, H., Soong, P. L., Tiburcy, M., Linke, W. A., Zaccolo, M., Hasenfuss, G. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56597-3 · Cited by 58
Pluripotent Stem Cells and Reprogrammed Cells in Farm Animals
Nowak‐Imialek, M., Kues, W. A., Carnwath, J. W., & Niemann, H. (2011) · Microscopy and Microanalysis · doi:10.1017/s1431927611000080 · Cited by 57
hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery
Li, J., Hua, Y., Miyagawa, S., Zhang, J., Li, L., Liu, L., & Sawa, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238893 · Cited by 57
Galimberti, E. S., & Knollmann, B. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.002 · Cited by 64
Modelling cadmium‐induced cardiotoxicity using human pluripotent stem cell‐derived cardiomyocytes
Shen, J., Wang, X., Zhou, D., Li, T., Tang, L. F. P., Gong, T., Su, J., & Liang, P. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13702 · Cited by 59
Winbo, A., Ramanan, S., Eugster, E., Jovinge, S. V., Skinner, J. R., & Montgomery, J. M. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00546.2020 · Cited by 61
Rajamohan, D., Kalra, S., Hoang, M. D., George, V. T., Staniforth, A., Russell, H., Yang, X., & Denning, C. N. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0253 · Cited by 63
Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism
Ulmer, B. M., & Eschenhagen, T. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.04.001 · Cited by 56
Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
Sala, L., Gnecchi, M., & Schwartz, P. J. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.1.1 · Cited by 54
Yong, U., Kim, D., Kim, H., Hwang, D. G., Cho, S., Nam, H., Kim, S., Kim, T. Y., Jeong, U., Kim, K., et al. (2022) · Advanced Materials · doi:10.1002/adma.202208983 · Cited by 58
Advances in cardiac tissue engineering and heart‐on‐a‐chip
Kieda, J., Shakeri, A., Landau, S., Wang, E. Y., Zhao, Y., Lai, B. F., Okhovatian, S., Wang, Y., Jiang, R., & Radisic, M. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37633 · Cited by 56
Cardiomyocytes derived from human pluripotent stem cells for drug screening
Zeevi‐Levin, N., Itskovitz‐Eldor, J., & Binah, O. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.005 · Cited by 54
Pluripotent stem cell applications for regenerative medicine
Angelos, M. G., & Kaufman, D. S. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000244 · Cited by 58
Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells
Csöbönyeiová, M., Polák, Š., & Danišovič, L. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0459 · Cited by 52
An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
Menon, S., Shailendra, S., Renda, A., Longaker, M. T., & Quarto, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010141 · Cited by 65
Embryonic type Na+ channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome
Okata, S., Yuasa, S., Suzuki, T., Ito, S., Makita, N., Yoshida, T., Li, M., Kurokawa, J., Seki, T., Egashira, T., et al. (2016) · Scientific Reports · doi:10.1038/srep34198 · Cited by 56
Modelling Human Disease with Pluripotent Stem Cells
Siller, R., Greenhough, S., Park, I., & Sullivan, G. J. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020004 · Cited by 60
Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Versatile Tool for Arrhythmia Research
Sinnecker, D., Goedel, A., Laugwitz, K., & Moretti, A. (2013) · Circulation Research · doi:10.1161/circresaha.112.268623 · Cited by 56
Self-citationPourrier, M., & Fedida, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020657 · Cited by 56
Balafkan, N., Mostafavi, S., Schubert, M., Siller, R., Liang, K. X., Sullivan, G. J., & Bindoff, L. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-73656-2 · Cited by 56
Ebert, A., Diecke, S., Chen, I. Y., & Wu, J. C. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201504395 · Cited by 54
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
Tanaka, A., Yuasa, S., Node, K., & Fukuda, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818894 · Cited by 54
Clinical Therapy Using iPSCs: Hopes and Challenges
Lu, X., & Zhao, T. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.002 · Cited by 60
Genetics of sudden cardiac death syndromes
Chopra, N., & Knollmann, B. C. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283459893 · Cited by 56
Zhou, R., Xu, A., Gingold, J. A., Strong, L. C., Zhao, R., & Lee, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.004 · Cited by 55
Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes
Shafaattalab, S., Lin, E. C., Christidi, E., Huang, H., Nartiss, Y., Garcia, A., Lee, J., Protze, S. I., Keller, G. M., Brunham, L. R., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.03.011 · Cited by 55
Heritable arrhythmias associated with abnormal function of cardiac potassium channels
Crotti, L., Odening, K. E., & Sanguinetti, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa068 · Cited by 52
Radke, M. H., Lisakowski, V. B., Britto‐Borges, T., Kubli, D. A., Jüttner, R., Parakkat, P., Carballo, J. L., Huettemeister, J., Liss, M., Hansen, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe8952 · Cited by 50
Stem Cells - biological update and cell therapy progress
Gîrlovanu, M., Șușman, S., Şoriţău, O., Rus-Ciuca, D., Melincovici, C. S., Constantin, A.-M., & Mihu, C. M. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-483 · Cited by 45
Greber, B., Verkerk, A. O., Seebohm, G., Mummery, C. L., & Bellin, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503762112 · Cited by 50
Self-citationConcise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells
Yang, C., Al-Aama, J. Y., Stojković, M., Keavney, B. D., Trafford, A. W., Lako, M., & Armstrong, L. (2015) · Stem Cells · doi:10.1002/stem.2070 · Cited by 53
New Opportunities: Harnessing Induced Pluripotency for Discovery in Diabetes and Metabolism
Teo, A. K. K., Wagers, A. J., & Kulkarni, R. N. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.010 · Cited by 50
Deshmukh, R. S., Kovács, K. A., & Dinnyés, A. (2012) · Stem Cells International · doi:10.1155/2012/379569 · Cited by 52
Stem Cells and Their Derivatives: A Renaissance in Cardiovascular Translational Research
Kattman, S. J., Koonce, C. H., Swanson, B. J., & Anson, B. D. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9235-1 · Cited by 50
Rodriguez, B., Carusi, A., Abi-Gerges, N., Ariga, R., Britton, O., Bub, G., Bueno-Orovio, A., Burton, R. A. B., Carapella, V., Cardone-Noott, L., et al. (2016) · Europace · doi:10.1093/europace/euv320 · Cited by 49
Three-dimensional microengineered models of human cardiac diseases
Veldhuizen, J., Migrino, R. Q., & Nikkhah, M. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0155-6 · Cited by 50
Schwartz, P. J. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa769 · Cited by 50
Label-free imaging for quality control of cardiomyocyte differentiation
Qian, T., Heaster, T. M., Houghtaling, A. R., Sun, K., Samimi, K., & Skala, M. C. (2021) · Nature Communications · doi:10.1038/s41467-021-24868-1 · Cited by 51
Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects
Kawashiri, M., Hayashi, K., Konno, T., Fujino, N., Ino, H., & Yamagishi, M. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0391-5 · Cited by 52
Systems biology approaches to heart development and congenital heart disease
Sperling, S. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr126 · Cited by 53
Ingrungruanglert, P., Amarinthnukrowh, P., Rungsiwiwut, R., Grand, S. M.-L., Sosothikul, D., Shotelersuk, V., Suphapeetiporn, K., & Israsena, N. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0503 · Cited by 50
New and TALENted Genome Engineering Toolbox
Campbell, J. M., Hartjes, K. A., Nelson, T. J., Xu, X., & Ekker, S. C. (2013) · Circulation Research · doi:10.1161/circresaha.113.301765 · Cited by 53
Chen, A., Ting, S., Seow, J., Reuveny, S., & Oh, S. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt401 · Cited by 49
Biel, N. M., Santostefano, K. E., DiVita, B. B., Rouby, N. M. E., Carrasquilla, S. D., Simmons, C. S., Nakanishi, M., Cooper‐DeHoff, R. M., Johnson, J. A., & Terada, N. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0126 · Cited by 54
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy
El‐Battrawy, I., Zhao, Z., Lan, H., Li, X., Yücel, G., Lang, S., Sattler, K., Schünemann, J.-D., Zimmermann, W., Cyganek, L., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001893 · Cited by 50
Update on Brugada Syndrome 2019
Coppola, G., Corrado, E., Curnis, A., Maglia, G., Oriente, D., Mignano, A., & Brugada, P. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.100454 · Cited by 51
Soares, F. A. C., Chandra, A., Thomas, R. J., Pedersen, R. A., Vallier, L., & Williams, D. J. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.12.009 · Cited by 47
Recent progress of iPSC technology in cardiac diseases
Funakoshi, S., & Yoshida, Y. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03172-3 · Cited by 52
Cutts, J., Nikkhah, M., & Brafman, D. A. (2015) · Biomarker Insights · doi:10.4137/bmi.s20313 · Cited by 50
The evolving field of induced pluripotency: Recent progress and future challenges
Sommer, C., & Mostoslavsky, G. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24155 · Cited by 50
Puppala, D., Collis, L. P., Sun, S. Z., Bonato, V., Chen, X., Anson, B. D., Pletcher, M. T., Fermini, B., & Engle, S. J. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs282 · Cited by 46
Bass, G. T., Ryall, K. A., Katikapalli, A., Taylor, B. E., Dang, S. T., Acton, S. T., & Saucerman, J. J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.009 · Cited by 46
Modeling rare diseases with induced pluripotent stem cell technology
Anderson, R. H., & Francis, K. R. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.01.001 · Cited by 53
Havasi, P., Nabioni, M., Soleimani, M., Bakhshandeh, B., & Parivar, K. (2013) · Molecular Biology Reports · doi:10.1007/s11033-012-2376-3 · Cited by 45
Skoglund, G., Lainé, J., Darabi, R., Fournier, E., Perlingeiro, R. C. R., & Tabti, N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322258111 · Cited by 45
Doyle, M. J., Lohr, J. L., Chapman, C. S., Koyano‐Nakagawa, N., Garry, M. G., & Garry, D. J. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9596-6 · Cited by 47
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes
Dell’Era, P. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.329 · Cited by 42
Zatti, S., Martewicz, S., Serena, E., Uno, N., Giobbe, G., Kazuki, Y., Oshimura, M., & Elvassore, N. (2014) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2013.1 · Cited by 43
Es‐Salah‐Lamoureux, Z., Jouni, M., Malak, O. A., Belbachir, N., Sayed, Z. R. A., Gandon-Renard, M., Lamirault, G., Gauthier, C., Baró, I., Charpentier, F., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.08.022 · Cited by 43
Sala, L., Oostwaard, D. W., Tertoolen, L. G. J., Mummery, C. L., & Bellin, M. (2017) · Journal of Visualized Experiments · doi:10.3791/55587 · Cited by 54
Self-citationStem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects
Samak, M., & Hinkel, R. (2019) · Cells · doi:10.3390/cells8121530 · Cited by 46
Precision Medicine and cardiac channelopathies: when dreams meet reality
Gnecchi, M., Sala, L., & Schwartz, P. J. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab007 · Cited by 46
Regenerative strategies for kidney engineering
Montserrat, N., Garreta, E., & Belmonte, J. C. I. (2016) · FEBS Journal · doi:10.1111/febs.13704 · Cited by 47
Genetics and Disease of Ventricular Muscle
Fatkin, D., Seidman, C. E., & Seidman, J. G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021063 · Cited by 47
Hong, L., Zhang, M., Ly, O. T., Chen, H., Sridhar, A., Lambers, E., Chalazan, B., Youn, S.-W., Maienschein-Cline, M., Feferman, L., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.04.019 · Cited by 44
“There is increasing interest in developing cellular models of disease that are genetically matched to specific patients using human induced pluripotent stem cells (iPSCs) (Itzhaki et al., 2011; Moretti et al., 2010).”
BackgroundInherited Arrhythmias in the Pediatric Population: An Updated Overview
Mariani, M. V., Pierucci, N., Fanisio, F., Laviola, D., Silvetti, G., Piro, A., Fazia, V. M. L., Chimenti, C., Rebecchi, M., Drago, F., et al. (2024) · Medicina · doi:10.3390/medicina60010094 · Cited by 46
Induced Pluripotent Stem Cells for the Study of Cardiovascular Disease
Savla, J. J., Nelson, B., Perry, C. N., & ADLER, E. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.038 · Cited by 48
Castiglioni, V., Onorati, M., Rochon, C., & Cattaneo, E. F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.032 · Cited by 48
Barbuti, A., Benzoni, P., Campostrini, G., & Dell'Era, P. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24455 · Cited by 42
The march of pluripotent stem cells in cardiovascular regenerative medicine
Abou-Saleh, H., Zouein, F. A., EL‐Yazbi, A. F., Sanoudou, D., Raynaud, C. M., Rao, C., Pintus, G., Dehaini, H., & Eid, A. H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0947-5 · Cited by 51
El‐Battrawy, I., Albers, S., Cyganek, L., Zhao, Z., Lan, H., Li, X., Xu, Q., Kleinsorge, M., Huang, M., Liao, Z., et al. (2019) · EP Europace · doi:10.1093/europace/euz122 · Cited by 44
Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists
van Doorn, E. C. H., Amesz, J. H., Sadeghi, A. H., de Groot, N. M. S., Manintveld, O. C., & Taverne, Y. J. H. J. (2024) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-023-00707-w · Cited by 49
Systems biology and cardiac arrhythmias
Grace, A. A., & Roden, D. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61462-7 · Cited by 44
Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes
Lewandowski, J., Kolanowski, T. J., & Kurpisz, M. K. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2117 · Cited by 47
Tidball, A. M., & Parent, J. M. (2015) · Stem Cells · doi:10.1002/stem.2203 · Cited by 47
Steinle, H., Weber, M., Behring, A., Mau-Holzmann, U. A., OHLE, C. V., Popov, A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.07.016 · Cited by 45
Song, L., Awari, D. W., Han, E. Y., Uche-Anya, E. N., Park, S.-H. E., Yabe, Y., Chung, W. K., & Yazawa, M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0245 · Cited by 44
iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery
Zhang, R., Zhang, L., & Xie, X. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.21 · Cited by 45
Therapeutic genome editing in cardiovascular diseases
Nishiga, M., Qi, L. S., & Wu, J. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.02.003 · Cited by 44
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
Gähwiler, E. K. N., Motta, S. E., Martin, M., Nugraha, B., Hoerstrup, S. P., & Emmert, M. Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639699 · Cited by 44
Induced pluripotent stem cells for cardiac repair
Zwi‐Dantsis, L., & Gepstein, L. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1078-2 · Cited by 43
Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine
Botman, O., & Wyns, C. (2014) · Frontiers in Surgery · doi:10.3389/fsurg.2014.00005 · Cited by 42
Kiviaho, A., Ahola, A., Larsson, K., Penttinen, K., Swan, H., Pekkanen-Mattila, M., Venäläinen, H., Paavola, K., Hyttinen, J., & Aalto‐Setälä, K. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.04.008 · Cited by 41
Experimental Models of Brugada syndrome
Sendfeld, F., Selga, E., Scornik, F. S., Pérez, G. J., Mills, N. L., & Brugada, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092123 · Cited by 42
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.